Please assess the completion status of the following clinical trial:

Trial Title: Multiple Dose Study To Investigate The Effects Of Fesoterodine And Solifenacin On Gastrointestinal Transit

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE1
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy female subjects~Exclusion Criteria:~* Evidence or history of clinically significant findings at screening

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: t

Study Arms:
- Fesoterodine (Type: EXPERIMENTAL): Tablets
- Placebo (Type: PLACEBO_COMPARATOR): Tablets
- Solifenacin (Type: ACTIVE_COMPARATOR): Tablets

Based on this trial design, predict the completion outcome and termination type (if applicable).